Certain receptors are associated with the reduction of microglial Aβ phagocytic capacity like triggering receptors expressed in myeloid cells 2 (TREM2), whose specific missense mutations increase the risk of AD (Jonsson et al., 2013; Parhizkar et al., 2019). The gene discussed is TREM2; the disease is Alzheimer disease.